Clinical trial
An Open-label, Multi-centre, Randomised, Two Arm Single Period Parallel Study to Assess the Efficacy, Safety and Utility of Hybrid Closed-loop Glucose Control Compared to Standard Insulin Therapy Combined With Continuous Glucose Monitoring in Young People (≥16 Years) and Adults With Cystic Fibrosis Related Diabetes (CL4P-CF Study)
NCT05562492 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multi-centre, Randomised, Two Arm Single Period Parallel Study to Assess the Efficacy, Safety and Utility of Hybrid Closed-loop Glucose Control Compared to Standard Insulin Therapy Combined With Continuous Glucose Monitoring in Young People (≥16 Years) and Adults With Cystic Fibrosis Related Diabetes (CL4P-CF Study)
- Lead sponsor
- University of Cambridge
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 12, 2023
- Completion date
- October 31, 2026
- Enrollment
- 128 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis-related diabetes